0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Vaccination intentions, readiness, and preferred attributes of a future Lassa fever vaccine among staff at a tertiary hospital in Edo State, Nigeria: A cross-sectional survey [Conference Abstract] August 17, 2025 by Irene Among
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Understanding gender dynamics, consent experiences, and community engagement in clinical trials in the context of a Lassa fever vaccine trial in Ghana [Conference Abstract] August 17, 2025 by Irene Among
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Sociocultural and environmental risk factors sustaining Lassa fever transmission in endemic communities of Edo State, Nigeria: Implications for targeted prevention strategies [Conference Abstract] August 17, 2025 by Irene Among
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Vaccines against Lassa fever virus (VITAL): Phase 1 safety and immunogenicity studies of a Lassa fever vaccine, ChAdOx1 LassaJ, in healthy volunteers in the UK and Ghana [Conference Abstract] August 16, 2025 by Irene Among
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Early dialysis and innovations for better outcome in Lassa fever patients with acute kidney injury [Conference Abstract] August 16, 2025 by Allan Mwesiga
0 Proceedings of the ECOWAS 2nd Lassa Fever International Conference in Abidjan September 2025 Hotspot mapping and vulnerability assessment to support participant recruitment for the CEPI ENABLE 1.5 Lassa fever prospective cohort study in Edo State, Nigeria [Conference Abstract] August 16, 2025 by Irene Among
